Acerca de
Novo Nordisk A/S is a Danish pharmaceutical company that specializes in diabetes and obesity care. Its 2025 sales grew 6.4% to DKK 309 billion (about $43 billion), led by 31% growth in obesity care. It is a global leader in diabetes, though its diabetes value market share slipped to 31.6% in the 12 months to Q3 2025.
